FDA Inspection 847232 — Montefiore's Institute For Reproductive Medicine And Health
The FDA completed an inspection of Montefiore's Institute For Reproductive Medicine And Health on Sep 6, 2013 in Hartsdale, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 6, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Hartsdale, NY (United States)